Gastrointestinal Cancers and HER2 Levels of Expression: Application of Biomarker Findings in Patients with Advanced Disease

PROGRAM CHAIR

John L. Marshall, MD
Physician Executive Director, Medstar Washington DC Integrated Hematology Oncology Division
Director, The Ruesch Center for the Cure of GI Cancers
Frederick P. Smith Endowed Chair
Chief Medical Officer, Lombardi Comprehensive Cancer Center
Georgetown University Medical Center
Washington, DC

FACULTY PRESENTERS

Thomas H. Cartwright, MD
Associate Professor of Medicine
University of Central Florida School of Medicine
Ocala, FL

Richard F. Dunne, MD, MS-CI
Associate Professor of Medicine
Leader, Gastrointestinal Cancer Unit
Wilmot Cancer Institute, University of Rochester
Rochester, NY

Ronan J. Kelly MD, MBA
Director of Oncology, Charles A. Sammons Cancer Center
Baylor University Medical Center
Dallas, TX

PROGRAM DESCRIPTION

This enduring program will provide clinicians who care for people with gastric and gastroesophageal junction cancers with important updates about current and future management of the diseases. It includes two animations and case study discussions.

TARGET AUDIENCE

This activity is designed to meet the educational needs of community medical oncologists, internal medicine physicians, primary care physicians, pathologists and others (e.g., nurse practitioner, pharmacist, physician assistant, oncology nurse) involved in the management of patients with gastric and gastroesophageal junction cancers.

LEARNING OBJECTIVES

  • Examine HER2 levels of expression and their application to patients with advanced gastric and gastroesophageal junction cancers
  • Apply both clinical trial findings and guideline recommendations to the treatment of patients with advanced HER2 gastric and gastroesophageal junction cancers
  • Discuss the recognition and management of HER2-targeted ADC treatment emergent adverse events in patients with gastrointestinal cancers

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


NURSES (ANCC) CREDIT DESIGNATION

Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hours.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)

Faculty Member  Disclosures
John L. Marshall, MD Discloses that he has served on a speakers bureau, and received fees for non-CME/CE services from Astra Zeneca, Merck, Bayer, Taiho, Seagen, Pfizer, Takeda, Arcus and Caris.
Thomas H. Cartwright, MD Has no relevant financial relationships to disclose.
Richard F. Dunne, MD, MS-CI Discloses that he has received consulting fees from Toray Industries Inc; and has served on an advisory board for Exelixis Inc. and Merck & Co.
Ronan J. Kelly MD, MBA Discloses that he has received consulting fees from Astra Zeneca, Daicchi Sankyo, Bristol Myers Squibb, Merck, Eli Lilly, Astellas, Toray, Allarity, Steris, Novocure, Illumina, Grail, Exact Sciences, OncoHost, Amgen, and Eisai; has served on a speakers bureau for Bristol Myers Squibb; and has received research funds from Bristol Myers Squibb and Eli Lilly.

All relevant financial relationships have been mitigated.

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

Staff, Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:

  • Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
  • Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
  • Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
  • Anita Mirsa-Press, Medical Director for Med Learning Group, has nothing to disclose.
  • Melissa A Johnson, Sr. Program Manager for Med Learning Group has nothing to disclose.
  • Millena DeBrito, Program Coordinator for Med Learning Group has nothing to disclose.
  • Russie Allen, Accreditation and Outcomes Manager for Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity.

In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.

Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group at [email protected]

RELEASED DATE: January 05, 2024
EXPIRATION DATE: January 05, 2025

Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

Healthcare Business Review Award

We are thrilled to announce that we have been recognized as one of the Top 10 Health Education Services Providers by Healthcare Business Review!

This award is both an honor and a testament to our cumulative dedication to providing the best continuing medical education (CME) services to HCPs across the globe. We are proud to be part of this distinguished group and look forward to continuing to have MLG be one of the best CME providers in the country.

Thank you to Healthcare Business Review for this recognition and for shining a light on the importance of accurate and accessible healthcare education.

#TopHealthEducationProvider #MedLearningGroup #HealthcareBusinessReview #MedicalEducation
BestofAmerica

Best of America Small Business Awards
Best Website

The Best of America Small Business Website award recognizes the best website launched by a small business since 2021. Technology is a key growth enabler for small businesses. The best in tech track recognizes small businesses as experts in technology and innovation from innovators, app developers, and website creators. Visit our award-winning Ophthalmology and Optometry web portal: vision-relief.com

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.